{
    "accessibility": "Open access",
    "additionDate": "2022-09-27T20:13:54.786779Z",
    "bioagentsCURIE": "bioagents:x-cap",
    "bioagentsID": "x-cap",
    "confidence_flag": "agent",
    "cost": "Free of charge",
    "credit": [
        {
            "email": "bejerano@stanford.edu",
            "name": "Gill Bejerano",
            "orcidid": "https://orcid.org/0000-0001-5179-3635",
            "typeEntity": "Person"
        },
        {
            "name": "David N. Cooper"
        },
        {
            "name": "Peter D. Stenson"
        },
        {
            "name": "Ruchir Rastogi"
        }
    ],
    "description": "X-CAP is a GBT model that predicts the pathogenicity of single-nucleotide stopgain variants. This repository contains the trained model as well as code to run X-CAP on a VCF file of variants.",
    "editPermission": {
        "type": "private"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "Genotyping",
                    "uri": "http://edamontology.org/operation_3196"
                },
                {
                    "term": "Variant calling",
                    "uri": "http://edamontology.org/operation_3227"
                },
                {
                    "term": "Variant effect prediction",
                    "uri": "http://edamontology.org/operation_0331"
                },
                {
                    "term": "Virulence prediction",
                    "uri": "http://edamontology.org/operation_3461"
                }
            ]
        }
    ],
    "homepage": "https://github.com/bejerano-lab/X-CAP",
    "language": [
        "Python"
    ],
    "lastUpdate": "2022-09-27T20:13:54.789667Z",
    "license": "MIT",
    "name": "X-CAP",
    "operatingSystem": [
        "Linux",
        "Mac",
        "Windows"
    ],
    "owner": "Jennifer",
    "publication": [
        {
            "doi": "10.1186/S13073-022-01078-Y",
            "metadata": {
                "abstract": "Â© 2022, The Author(s).Stopgain substitutions are the third-largest class of monogenic human disease mutations and often examined first in patient exomes. Existing computational stopgain pathogenicity predictors, however, exhibit poor performance at the high sensitivity required for clinical use. Here, we introduce a new classifier, termed X-CAP, which uses a novel training methodology and unique feature set to improve the AUROC by 18% and decrease the false-positive rate 4-fold on large variant databases. In patient exomes, X-CAP prioritizes causal stopgains better than existing methods do, further illustrating its clinical utility. X-CAP is available at https://github.com/bejerano-lab/X-CAP.",
                "authors": [
                    {
                        "name": "Bejerano G."
                    },
                    {
                        "name": "Cooper D.N."
                    },
                    {
                        "name": "Rastogi R."
                    },
                    {
                        "name": "Stenson P.D."
                    }
                ],
                "date": "2022-12-01T00:00:00Z",
                "journal": "Genome Medicine",
                "title": "X-CAP improves pathogenicity prediction of stopgain variants"
            },
            "pmcid": "PMC9338606",
            "pmid": "35906703"
        }
    ],
    "agentType": [
        "Command-line agent"
    ],
    "topic": [
        {
            "term": "Exome sequencing",
            "uri": "http://edamontology.org/topic_3676"
        },
        {
            "term": "Genetic variation",
            "uri": "http://edamontology.org/topic_0199"
        },
        {
            "term": "Genomics",
            "uri": "http://edamontology.org/topic_0622"
        },
        {
            "term": "Machine learning",
            "uri": "http://edamontology.org/topic_3474"
        },
        {
            "term": "RNA-Seq",
            "uri": "http://edamontology.org/topic_3170"
        }
    ]
}
